Literature DB >> 25832660

Head injury does not alter disease progression or neuropathologic outcomes in ALS.

Christina N Fournier1, Marla Gearing2, Saila R Upadhyayula2, Mitch Klein2, Jonathan D Glass2.   

Abstract

OBJECTIVES: To study the effects of head injury on disease progression and on neuropathologic outcomes in amyotrophic lateral sclerosis (ALS).
METHODS: Patients with ALS were surveyed to obtain head injury history, and medical records were reviewed. Linear regression was performed to determine if head injury was a predictor for mean monthly decline of Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R), while controlling for confounders. Head injury history was obtained from family members of ALS autopsy cases. The frequency of tau proteinopathy, brain TDP-43 inclusions, and pathologic findings of Alzheimer disease (AD) were examined in ALS cases with head injury compared to cases without. Logistic regression was performed with each neuropathologic diagnosis as an outcome measure and head injury as a predictor variable.
RESULTS: No difference was seen in rate of decline of the ALSFRS-R between patients with head injury (n = 24) and without (n = 76), with mean monthly decline of -0.9 for both groups (p = 0.18). Of 47 ALS autopsy cases (n = 9 with head injury, n = 38 without), no significant differences were seen in the frequency of tau proteinopathy (11% with head injury; 24% without), TDP-43 in the brain (44% with head injury; 45% without), or AD pathology (33% with head injury; 26% without). Independent logistic regression models showed head injury was not a predictor of tau pathology (p = 0.42) or TDP-43 in the brain (p = 0.99).
CONCLUSIONS: Head injury was not associated with faster disease progression in ALS and did not result in a specific neuropathologic phenotype. The tau pathology described with chronic traumatic encephalopathy was found in ALS autopsy cases both with and without head injury.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832660      PMCID: PMC4424128          DOI: 10.1212/WNL.0000000000001522

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Trauma, TDP-43, and amyotrophic lateral sclerosis.

Authors:  Stanley H Appel; Valerie A Cwik; John W Day
Journal:  Muscle Nerve       Date:  2010-12       Impact factor: 3.217

2.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

3.  The natural history of ALS is changing: improved survival.

Authors:  Muddasir Qureshi; David A Schoenfeld; Yuvika Paliwal; Amy Shui; Merit E Cudkowicz
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 4.  Is head trauma a risk factor for amyotrophic lateral sclerosis? An evidence based review.

Authors:  Carmel Armon; Lorene M Nelson
Journal:  Amyotroph Lateral Scler       Date:  2012-03-16

5.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

6.  High school football and risk of neurodegeneration: a community-based study.

Authors:  Rodolfo Savica; Joseph E Parisi; Lester E Wold; Keith A Josephs; J Eric Ahlskog
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

7.  A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.

Authors:  L Lacomblez; G Bensimon; P N Leigh; P Guillet; L Powe; S Durrleman; J C Delumeau; V Meininger
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

8.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

9.  Head injury and amyotrophic lateral sclerosis.

Authors:  Honglei Chen; Marie Richard; Dale P Sandler; David M Umbach; Freya Kamel
Journal:  Am J Epidemiol       Date:  2007-07-19       Impact factor: 4.897

10.  Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study.

Authors:  Sonja W de Jong; Mark H B Huisman; Nadia A Sutedja; Anneke J van der Kooi; Marianne de Visser; Helenius J Schelhaas; Kathelijn Fischer; Jan H Veldink; Leonard H van den Berg
Journal:  Am J Epidemiol       Date:  2012-07-11       Impact factor: 4.897

View more
  13 in total

1.  Meta-analytic evaluation of the association between head injury and risk of amyotrophic lateral sclerosis.

Authors:  Yukari Watanabe; Takamitsu Watanabe
Journal:  Eur J Epidemiol       Date:  2017-10-27       Impact factor: 8.082

2.  Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank.

Authors:  Kevin F Bieniek; Owen A Ross; Kerry A Cormier; Ronald L Walton; Alexandra Soto-Ortolaza; Amelia E Johnston; Pamela DeSaro; Kevin B Boylan; Neill R Graff-Radford; Zbigniew K Wszolek; Rosa Rademakers; Bradley F Boeve; Ann C McKee; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-10-30       Impact factor: 17.088

Review 3.  Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench.

Authors:  Colin K Franz; Divya Joshi; Elizabeth L Daley; Rogan A Grant; Kyriakos Dalamagkas; Audrey Leung; John D Finan; Evangelos Kiskinis
Journal:  J Neurophysiol       Date:  2019-05-22       Impact factor: 2.714

4.  Mild Chronic Traumatic Encephalopathy Neuropathology in People With No Known Participation in Contact Sports or History of Repetitive Neurotrauma.

Authors:  Grant L Iverson; Teemu M Luoto; Pekka J Karhunen; Rudolph J Castellani
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

5.  Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort.

Authors:  Gabriel S Walt; Hannah M Burris; Christopher B Brady; Keith R Spencer; Victor E Alvarez; Bertrand R Huber; Latease Guilderson; Nazifa Abdul Rauf; Derek Collins; Tarnjit Singh; Rebecca Mathias; James G Averill; Sean E Walker; Ian Robey; Ann C McKee; Neil W Kowall; Thor D Stein
Journal:  J Neuropathol Exp Neurol       Date:  2018-12-01       Impact factor: 3.685

6.  Tau deposition in the spinal cord is not specific for CTE-ALS.

Authors:  Christina N Fournier; Marla Gearing; Jonathan D Glass
Journal:  Neurology       Date:  2020-06-02       Impact factor: 9.910

Review 7.  Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies.

Authors:  Francisco J Carvajal; Hayley A Mattison; Waldo Cerpa
Journal:  Neural Plast       Date:  2016-08-18       Impact factor: 3.599

8.  Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients.

Authors:  Nina Feddermann-Demont; Astrid Junge; Konrad P Weber; Michael Weller; Jiří Dvořák; Alexander A Tarnutzer
Journal:  Brain Behav       Date:  2017-03-16       Impact factor: 2.708

Review 9.  National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome.

Authors:  Douglas I Katz; Charles Bernick; David W Dodick; Jesse Mez; Megan L Mariani; Charles H Adler; Michael L Alosco; Laura J Balcer; Sarah J Banks; William B Barr; David L Brody; Robert C Cantu; Kristen Dams-O'Connor; Yonas E Geda; Barry D Jordan; Thomas W McAllister; Elaine R Peskind; Ronald C Petersen; Jennifer V Wethe; Ross D Zafonte; Éimear M Foley; Debra J Babcock; Walter J Koroshetz; Yorghos Tripodis; Ann C McKee; Martha E Shenton; Jeffrey L Cummings; Eric M Reiman; Robert A Stern
Journal:  Neurology       Date:  2021-03-15       Impact factor: 11.800

Review 10.  The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.

Authors:  Grant L Iverson; C Dirk Keene; George Perry; Rudolph J Castellani
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.